Seattle Genetics has promoted Dr. Vaughn Himes to the new role of chief technical officer and Dr. Dennis Benjamin to senior vice president, translational research.
The Bothell-based biotech firm also announced the appointment of Dr. Robert Lechleider as senior vice president, clinical development.
Himes has been with Seattle Genetics (Nasdaq: SGEN) since 2009. He most recently served as executive vice president of process sciences and technical operations.
